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Importance 
Lymphocytic choriomeningitis virus (LCMV) is a pathogen, normally carried in 
rodents, which can cause aseptic meningitis and other conditions in humans. Most 
people experience a relatively mild illness and fatal infections are rare; however, 
pregnant women may give birth to congenitally infected infants with severe defects of 
the brain and eye. In a few instances, this virus has been transmitted in transplanted 
organs, usually resulting in fatal disease. LCMV infections in rodents are often 
subclinical, although acute clinical signs or chronic effects may be seen in some 
animals. Some strains of this virus can cause life-threatening illness in New World 
monkeys. LCMV is also a potential bioterrorist weapon. 
Etiology 
The lymphocytic choriomeningitis virus is a member of the genus Arenavirus and 
family Arenaviridae. There are many strains of this virus with varying pathogenicity.  
LCMV is classified in the Lassa-Lymphocytic choriomeningitis (Old World) 
serocomplex of arenaviruses. Two recently discovered viruses in this complex 
might be able to cause similar illnesses. Kodoko virus, which was detected in Mus 
Nannomys minutoides (pygmy mice) in Guinea, West Africa, is closely related to 
LCMV. Its potential to cause disease in humans is unknown. Dandenong virus was 
isolated from Australian transplant patients who developed a fatal, febrile illness with 
encephalitis. The virus was transmitted in organs from a donor who had recently 
returned from a trip to the former Yugoslavia. Its reservoir host, which is probably a 
rodent, is unknown. 
Geographic Distribution 
LCMV probably occurs worldwide wherever its natural host, the house mouse 
(Mus musculus) can be found. This rodent has become established on all continents 
except Antarctica. Although serological evidence suggests that LCMV circulates in 
Africa, cross-reactions can occur with other arenaviruses and there is no definitive 
evidence of its presence there.  
Transmission 
Infected rodents can shed LCMV in the saliva, nasal secretions, urine, milk, 
feces and semen. This virus can be transmitted in aerosols, or through abraded skin 
and mucous membranes. It can be acquired via bites. Monkeys have become 
infected after eating infected mice; oral transmission in contaminated food or water 
may also be possible in other species. Transplacental transmission can occur in 
rodents and humans.  
Viral persistence and shedding varies with the host and its age when it is infected. 
Persistent infections occur in some mice (M musculus) and hamsters that are exposed 
in utero or as newborns. These animals can shed the virus lifelong. Other mice and 
hamsters infected during the neonatal period may develop only transient viremia. 
Rodents infected after this time usually clear the virus completely. Chronic infections 
have not been reported in other species, including congenitally infected humans. 
People can become infected by direct contact with infected rodents, or indirect 
contact with the virus in excretions and secretions from rodents (e.g., by inhalation). 
Human infections have been documented after contact with infected mice, hamsters 
and guinea pigs. Zoonotic transmission from other wild and pet rodents may be 
possible, and seroconversion has been reported after bites from infected primates. 
LCMV, which is a noncytopathic virus, can also contaminate some cell cultures and 
cause laboratory-acquired infections. Person-to-person transmission does not seem to 
occur, except in organ transplants or from mother to child across the placenta. 
LCMV has been isolated from fleas, ticks, cockroaches and Culicoides and 
Aedes mosquitoes. Ticks, lice and mosquitoes have been shown to transmit this 
virus mechanically in the laboratory. If arthropod-mediated spread occurs in nature, 
it is thought to play only a minor role in the epidemiology of this disease. 
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Disinfection 
LCMV is susceptible to most detergents and 
disinfectants including 1% sodium hypochlorite, 70% 
ethanol, 2% glutaraldehyde and formaldehyde. Infectivity 
is lost quickly below pH 5.5 and above pH 8.5. LCMV 
can also be inactivated by heat, ultraviolet light or gamma 
irradiation. 
Infections in Humans 
Incubation Period 
In humans, the symptoms of acute disease usually 
appear 5 to 13 days after exposure. In cases with 
meningitis, central nervous system (CNS) signs usually 
develop 15 to 21 days after infection. Patients infected in 
solid organ transplants have become symptomatic within a 
few weeks of transplantation. 
Clinical Signs 
Most infections in immunocompetent individuals are 
asymptomatic or characterized by a mild, self-limiting 
illness. The symptoms are flu-like and may include fever, 
fatigue, malaise, anorexia, headache, sore throat, myalgia, 
photophobia, and gastrointestinal signs such as nausea and 
vomiting. Coughing, rashes, joint aches and chest pain are 
sometimes seen. In most cases, the symptoms resolve 
without treatment within a few days. Occasionally, a 
patient improves for a few days, then relapses with aseptic 
meningitis, or very rarely, meningoencephalitis. 
Patients with meningitis may have a stiff neck, fever, 
headache, myalgia, nausea and malaise. Occasionally, 
meningitis occurs without a prodromal syndrome. 
Meningoencephalitis is characterized by more profound 
neurological signs such as confusion, drowsiness, sensory 
abnormalities and motor signs. Uncommonly reported 
complications include myelitis, Guillain-Barre-type 
syndrome, cranial nerve palsies, transient or permanent 
hydrocephalus, sensorineural hearing loss, orchitis, 
arthritis and parotitis. LCMV infections have also been 
implicated in pancreatitis, pneumonitis, myocarditis and 
pericarditis. The entire illness usually lasts 1 to 3 weeks, 
and most people recover even from severe meningitis 
without sequelae. However, temporary or permanent 
neurological damage is possible in all CNS infections, 
particularly in cases of meningoencephalitis. Deaths are 
rare. Chronic infections have not been reported in humans. 
Prenatal infections can result in abortions, acute 
neonatal meningitis or severe developmental defects in the 
fetus. The mother may or may not recall a febrile illness 
during the pregnancy. Common CNS defects in the fetus 
include hydrocephalus, microcephaly, cerebellar hypoplasia 
and periventricular calcification. Chorioretinitis, which is 
followed by chorioretinal scarring, is the most common 
ocular lesion. Other ocular defects including optic atrophy, 
microphthalmia, vitreitis, leukokoria and cataracts can also 
be seen. Most of the infants in one case series were of 
normal birth weight, although 30% were underweight. 
Some congenitally infected infants may eventually improve 
to some extent, but most neither improve nor become 
worse. Aspiration pneumonia can be a fatal complication. 
Infants who survive may have severe neurological defects 
including epilepsy, impaired coordination, visual loss or 
blindness, spastic diplegia or quadriparesis/quadriplegia, 
delayed development and mental retardation. Less severe 
cases with isolated cerebellar hypoplasia and symptoms of 
ataxia and jitteriness have been reported occasionally. 
There have also been rare cases with evidence of 
chorioretinitis but without neurological signs. Systemic 
signs seem to be rare, but hepatosplenomegaly, 
thrombocytopenia and hyperbilirubinemia have been 
documented in a few cases, and skin blisters were reported 
in one infant. The full spectrum of congenital disease may 
still be unknown. 
Patients infected in solid organ transplants have 
developed a severe fatal illness, starting within weeks of the 
transplant. In the cases reported to date, the initial 
symptoms included fever, lethargy, anorexia and 
leukopenia, and quickly progressed to multisystem organ 
failure, hepatic insufficiency or severe hepatitis, 
dysfunction of the transplanted organ, coagulopathy, 
hypoxia, multiple bacteremias and shock. Localized rash 
and diarrhea were also seen in some patients. Nearly all 
cases have been fatal. 
Other rare syndromes have also been described. Fatal 
illnesses that resembled viral hemorrhagic fever were 
reported in one person who had conducted a necropsy on an 
infected monkey, and in an individual who autopsied the 
person who died. The monkey had been inoculated with 
brain tissue from a patient with encephalitis. Severe cases 
of viral hemorrhagic fever, a disease that is usually caused 
by arenaviruses other than LCMV, are characterized by a 
multisystemic disease with hypotension, edema, shock, 
bleeding tendencies and neurological signs. (See the viral 
hemorrhagic fever factsheet for a full description of this 
disease.) Fatal multisystemic illness was also reported in 
three lymphoma patients who had failed conventional 
therapy and had been given LCMV to induce tumor 
regression. 
Communicability 
LCMV does not seem to be transmitted from person to 
person, except to the fetus in utero or  in transplanted 
organs. 
Diagnostic Tests 
Lymphocytic choriomeningitis is usually diagnosed in 
humans by serology, but virus isolation and other tests can 
also be used.  
Acute infections can be diagnosed by detecting virus-
specific IgM or a rising antibody titer. Antibodies to LCMV 
may also be found in the cerebrospinal fluid (CSF). In 
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congenital infections, the virus has usually been cleared by 
the time the infant is born; in most cases, both the mother 
and infant have specific IgG, and IgM is absent. The most 
commonly used serological tests are the indirect 
immunofluorescence assay (IFA) and enzyme-linked 
immunosorbent assays (ELISAs). Both tests can detect 
either IgM or IgG. The ELISA test for LCMV antibodies 
may not be widely available; in the U.S., it is performed at 
the Special Pathogens Branch at the Centers for Disease 
Control and Prevention (CDC). The complement fixation 
test is relatively insensitive.  
Reverse transcription polymerase chain reaction (RT-
PCR) tests may detect nucleic acids in the blood and CSF.  
Virus isolation is not used for diagnosis in most cases. 
In the U.S., this test is also available at the CDC. LCMV 
may be isolated from the blood or nasopharyngeal fluid 
early in the course of the disease, or from CSF in patients 
with meningitis. In congenitally infected infants, the virus 
has usually been cleared by birth. LCMV can be grown in a 
variety of cell lines including BHK21, L and Vero cells, 
and it may be identified with immuno-fluorescence. A 
diagnosis can also be made by the intracerebral inoculation 
of blood or CSF into mice.  
LCMV cannot always be detected in donors who have 
transmitted this virus to transplant recipients. Three clusters 
of transplant-associated cases were reported in the U.S. 
from 2005 to 2010. Neither of the first two donors had a 
history of an acute infectious disease, and RT-PCR tests 
and serology did not detect LCMV. In one case, a 
genetically identical virus was, however, detected in the 
donor’s pet hamster. The third donor died of an illness 
characterized by fever and neurological signs, and an 
antemortem serum sample later tested positive for LCMV-
specific IgM and IgG.  
Treatment 
Treatment is symptomatic and supportive. Children 
with hydrocephalus often need a ventriculoperitoneal 
shunt. Ribavirin is not used routinely in the treatment of 
lymphocytic choriomeningitis; however, it has been 
promising in anecdotal reports, and has been 
recommended especially for immunocompromised 
patients and others who are severely ill. The only survivor 
of a transplant-associated LCMV infection was treated 
with ribavirin and simultaneous tapering of the 
immunosuppressive medications. Ribavirin has not been 
evaluated yet in controlled clinical trials. It is also 
teratogenic.  
Prevention 
Most human infections result from exposure to infected 
mice. The risk of infection from wild mice can be decreased 
by ensuring that buildings and their surrounding areas are 
unattractive to rodents, and by preventing these animals 
from entering the home. For example, food that may attract 
rodents (including pet food and birdseed) should be kept in 
rodent-proof containers, and holes where mice may enter 
the house should be sealed with steel wool, caulk or metal. 
Wild mice should be exterminated or removed if they are 
present in the home. Direct contact should be avoided; live 
or dead mice should not be touched with the bare hands. 
Information on safely cleaning a rodent-infested area is 
available from the CDC. It is particular important to avoid 
aerosolizing the virus during this process. 
Laboratory colonies of domesticated mice should be 
tested regularly for LCMV. The risks associated with 
handling wild-caught rodents should be kept in mind by 
those who work with them. Personal protective equipment 
(PPE) and other precautions should be used as appropriate. 
Safe handling practices to prevent bites, with appropriate 
PPE, should also be used when handling or performing 
necropsies on New World primates. Seroconversion 
occurred in two zoo veterinarians who were bitten by 
infected primates or performed necropsies during outbreaks 
of callitrichid hepatitis. Cell lines susceptible to LCMV 
should be bought from reputable commercial suppliers that 
supply screened cells. 
Cases of lymphocytic choriomeningitis are rarely 
attributed to pet rodents. Good hygiene can help prevent 
infections from these animals. The hands should be washed 
with soap and water after handling rodents, their cages, 
bedding and any other object that may be contaminated 
with droppings or urine. Cages should be kept clean and 
free of soiled bedding; cleaning is best done in a well-
ventilated area or outside. Pet rodents should be kept away 
from the face. Young children should be supervised when 
handling rodents, to ensure that they practice good hygiene. 
Because tests are for LCMV are unreliable in individual 
animals, the CDC does not recommend testing pet rodents 
for this virus. 
Particular care should be taken to avoid contact with 
rodents during pregnancy. Pregnant women should avoid 
touching wild or pet rodents or their droppings, and they 
should not stay for long periods in rooms where these 
animals are present. For the duration of the pregnancy, pet 
rodents should be kept in a separate area of the home and 
cared for by another family member or friend. Another 
option would be to care for the animal temporarily in 
someone else’s home. Infestations by wild mice should be 
handled by a professional pest control company or another 
member of the household. Pregnant women who work with 
rodents should wear gloves, gowns, and face masks. 
Precautions to avoid infections from callitrichid primates 
are also advisable during pregnancy. 
Morbidity and Mortality 
Lymphocytic choriomeningitis is uncommonly 
reported in humans; however, most infections are mild and 
are probably never diagnosed. Serological surveys suggest 
that approximately 1-5% of the population in the U.S. and 
Europe has antibodies to LCMV. The prevalence varies 
with the living conditions and exposure to mice, and may 
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have been higher in the past. Laboratory personnel who 
handle rodents or infected cells have an increased risk of 
infection.  
In temperate climates, most cases occur during the fall 
or winter when mice move indoors. Lymphocytic 
choriomeningitis tends to occur as isolated cases, but a few 
outbreaks have been associated with infected laboratory 
rodents, tumor-cell lines used in research, or pet hamsters 
acquired from infected colonies. Approximately 10-20% of 
the cases in immunocompetent individuals are thought to 
progress to neurological disease, mainly as aseptic 
meningitis. The overall case fatality rate is less than 1% and 
people with complications, including meningitis, almost 
always recover completely. Rare cases of 
meningoencephalitis can also be seen. More severe disease 
is likely to occur in people who are immunosuppressed. 
More than 50 infants with congenital LCMV infection 
have been reported worldwide. The probability that a 
woman will become infected after being exposed to 
rodents, the frequency with which LCMV crosses the 
placenta, and the likelihood of clinical signs among these 
infants are still poorly understood. In one study, antibodies 
to LCMV were detected in 0.8% of normal infants, 2.7% of 
infants with neurological signs and 30% of infants with 
hydrocephalus. Other researchers reported that only one of 
approximately 450 infants with major medical conditions 
(e.g., prematurity, CNS signs, congenital malformations 
and other syndromes) had been infected with this virus. In 
Argentina, no congenital LCMV infections were reported 
among 288 healthy mothers and their infants. However, one 
study found that two of 95 children in a home for people 
with severe mental disabilities had probably been infected 
with this virus. The prognosis for severely affected infants 
appears to be poor. In one series, 35% of infants diagnosed 
with congenital infections had died by the age of 21 
months. Most of the remaining children had serious, 
permanent neurological defects. The symptoms were 
moderately severe in some others, and a few children were 
normal. However, it should be noted that less severely 
affected or asymptomatic babies may not be recognized, as 
LCMV testing is not routinely performed.  
Transplant-acquired lymphocytic choriomeningitis 
appears to have a very high morbidity and mortality rate. In 
the three clusters reported in the U.S. from 2005 to 2010, 
nine of the ten infected recipients died. One donor had been 
infected from a recently acquired pet hamster; the sources 
of the virus in the other cases were unknown.  
Infections in Animals 
Species Affected 
The house mouse (Mus musculus) is the primary 
reservoir host for LCMV. This virus or a variant also occurs 
in the wood mouse (Apodemus sylvaticus) and the yellow-
necked mouse (Apodemus flavicollis). Hamster populations 
can act as reservoir hosts. Other rodents including guinea 
pigs, rats and chinchillas can be infected but do not appear 
to maintain the virus. LCMV can cause illness in New 
World primates such as macaques, marmosets and tamarins. 
Infections have also been reported in rabbits, dogs and pigs 
Incubation Period 
After experimental inoculation, the incubation period 
in adult mice is 5 to 6 days. Congenitally or neonatally 
infected mice and hamsters do not become symptomatic for 
several months or longer. 
Clinical Signs 
Mice 
In mice, the clinical signs vary with the host’s 
resistance and age at infection, as well as the strain of the 
virus. Mice infected in utero or during the first few days 
after birth may become persistently infected and shed the 
virus for life. These mice can suffer growth retardation, 
particularly during the first three weeks, but otherwise 
remain asymptomatic for several months. After 5 to 12 
months, persistently infected mice may develop 
glomerulonephritis accompanied by weight loss, 
emaciation, ruffled fur, hunched posture and ascites. Life 
expectancy can be decreased by a few months. In addition, 
reproductive success may be impaired, and infected female 
mice may give birth to stunted litters. 
In mice more than a few days old, LCMV is recognized 
as foreign. Some infected mice remain asymptomatic and 
clear the virus. Others become acutely ill; the clinical signs 
may include blepharitis, weakness, convulsions, tremors, 
photophobia, growth retardation and a rough hair coat. 
Mice with acute disease either die within a few days to 
weeks or recover completely. These mice do not become 
chronically infected. In some strains of mice, LCMV 
infection is associated with an increased incidence of 
lymphoma. Generalized immunosuppression can also 
occur.  
Choriomeningoencephalitis is usually seen only after 
experimental intracerebral inoculation. 
Hamsters 
Runting, reduced litter sizes, glomerulonephritis and 
chronic generalized vasculitis have been reported in some 
persistently infected hamsters. Lethargy, anorexia and a 
rough coat may be seen in the early stages. Later, there may 
be weight loss, a hunched posture and blepharitis. Affected 
mice may die. Hamsters infected after the neonatal period 
become viremic and may shed the virus for a time, but seem 
to remain asymptomatic. 
Rats 
Experimental intracerebral infection of suckling rats 
results in microcephaly, retinitis and the destruction of 
several brain regions, leading to permanent abnormalities of 
movement, coordination, vision and behavior.  
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Primates 
LCMV causes callitrichid hepatitis in New World 
primates. The initial signs are nonspecific and may include 
fever, anorexia, dyspnea, weakness and lethargy. Jaundice 
is characteristic and petechial hemorrhages may develop. 
These signs are often followed by prostration and death. 
Communicability 
In rodents, LCMV is shed in urine, saliva, feces, milk 
and semen. Mice infected in utero or during the neonatal 
period may shed the virus for life. Some persistently 
infected hamsters also shed the virus for at least eight 
months, while others seem to clear the virus at 
approximately three months of age. Hamsters infected after 
the neonatal period can shed the virus for 3 to 6 months. 
Vertical transmission has been reported in mice and 
hamsters. 
Post Mortem Lesions 
Rodents 
Gross lesions reported in mice include hepatomegaly, 
splenomegaly, lymphadenopathy, and swollen or shrunken 
and pitted kidneys due to glomerulonephritis. Histological 
findings in persistently infected mice often include chronic 
glomerulonephritis. In these mice, there may also be 
vasculitis and lymphocytic infiltrates in many organs and 
tissues including the liver, spleen, lung, kidneys, pancreas, 
blood vessels, meninges and brain.  
Chronic glomerulonephritis and chronic generalized 
vasculitis have been reported in persistently infected 
hamsters. 
Primates 
Necropsy lesions in primates with callitrichid hepatitis 
may include jaundice, hepatomegaly, splenomegaly, and 
subcutaneous and intramuscular hemorrhages. Pleural and 
pericardial effusion, sometimes sanguineous, may be seen. 
On histology, multifocal necrosis with acidophilic bodies 
and mild inflammatory infiltrates are typically found in the 
liver. Other organs including the spleen, lymph nodes, 
adrenal glands, intestine, pancreas and central nervous 
system may also be affected. 
Diagnostic Tests 
Rodents 
In rodents, lymphocytic choriomeningitis can be 
diagnosed by virus isolation, the detection of viral antigens 
or serology.  
LCMV can be isolated in a variety of cell lines 
including BHK21, L and Vero cells; the virus may be 
identified with immunofluorescence. Animal inoculation 
into mice can also be used to recover this virus. 
Immunostaining can detect viral antigens in tissues 
including the liver, and RT-PCR can detect viral RNA.  
Serological tests that have been used in rodents include 
immunofluorescence (IFA), the microplaque-reduction test 
for neutralizing antibody, and ELISAs. Complement 
fixation has been employed, but it is relatively insensitive. 
Serology is useful in rodent colonies, but it is not 
completely reliable for identifying infections in individual 
rodents. 
Primates 
In monkeys, viral antigens or nucleic acids can be 
detected by immunostaining or in situ hybridization of the 
liver. Virus isolation, RT-PCR and serologic tests can also 
be used.  
Treatment 
There is no specific treatment for lymphocytic 
choriomeningitis. Infected hamster and mouse colonies are 
usually destroyed. Treatment in non-human primates is 
supportive and symptomatic. 
Prevention 
Wild rodents should not be allowed to contact pet 
rodents, breeding colonies, laboratory rodents or New 
World monkeys. Precautions such as keeping feed in 
sealed containers can make facilities less attractive to 
these animals. Mice and rats that enter buildings should be 
exterminated. Primates should not be fed mice that may be 
positive for LCMV. Captive mouse and hamster colonies 
should be obtained from LCMV-free populations. These 
animals should be re-tested periodically to confirm that 
they remain free of this virus. Good hygiene and 
disinfection can help prevent transmission between 
captive rodents, as well as from wild to captive rodents, 
on fomites. Filter cage covers can reduce aerosol 
transmission. Arthropods should also be controlled. 
When bringing a new pet rodent into the home, it is 
difficult to be sure it is LCMV-free, as many infections 
are asymptomatic. In general, only active, alert animals 
with no obvious signs of disease (either in the individual 
animal or in cage mates and nearby rodents) should be 
chosen. Pets should be selected, if possible, from a pet 
shop or other source that has a health monitoring program. 
Any cage or other equipment previously used for rodents 
should be cleaned and disinfected before reuse. 
Serological testing is not reliable for ensuring that an 
individual rodent is LCMV-free; testing of pets is not 
recommended by the CDC. Pet rodents that die should be 
handled with gloves and double-bagged, and their cage 
and environment should be cleaned and disinfected. If an 
animal dies soon after being taken home, the pet store 
should be informed, as the animal might have died of an 
infectious disease that has affected other animals in the 
shop. 
Infected colonies of research animals are usually 
euthanized. Outbreaks in pet rodents have been controlled 
by destroying the breeding stocks and disinfecting the 
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premises. If there are biosecurity issues that allow 
transmission from wild mice, they must also be corrected. 
Some individual states have allowed some animals (e.g., 
hamsters) received from an infected distributor to be sold or 
adopted with an information leaflet or informed consent; in 
other cases, the sale of all animals that might have been 
exposed was prohibited. LCMV infections are reportable by 
veterinarians in some states. 
Morbidity and Mortality 
LCMV infections are focal; this virus is often carried in 
one population of rodents without affecting others. 
Estimates of its prevalence in wild mouse populations range 
from 0% to 60%, with an average prevalence of 9%. The 
incidence of LCMV in pet rodents is unknown; however, 
very few human cases have been associated with exposure 
to pets. In the U.S., when infected pet hamsters have been 
found, all of the animals have usually been traced to a 
single breeding colony. In the transplant-associated cases 
linked to a pet hamster in 2005, two other hamsters and a 
guinea pig at the pet shop, and approximately 4% of the 
hamsters at the distributor, were also infected. 
Morbidity and mortality rates vary with the species of 
animal and its age at infection, as well as the strain of the 
virus and route of exposure. Neonatally and congenitally 
infected mice remain asymptomatic for many months, but 
the onset of glomerulonephritis reduces overall life 
expectancy. The morbidity rate in naturally infected post-
neonatal mice is unknown; however, subclinical disease 
may be the most common form, as few natural outbreaks 
have been reported.  
In hamsters, approximately half of all congenitally 
infected animals clear the virus when they are 
approximately three months old and remain healthy; the 
remaining animals develop chronic disease. Hamsters 
infected as adults usually remain asymptomatic.  
Callitrichid hepatitis is reported to be highly fatal in 
naturally infected marmosets and tamarins in zoos. Since 
1980, 12 outbreaks with 57 deaths have been reported in the 
U.S. In experimentally infected rhesus macaques, three of 
four animals became fatally ill when inoculation was by the 
intravenous route. In contrast, inoculation by the 
intragastric route usually led to asymptomatic infections, 
with occasional disease and few deaths. 
Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages
/lcmv.htm 
Medical Microbiology 
http://www.ncbi.nlm.nih.gov/books/NBK7627/ 
Public Health Agency of Canada.  
Material Safety Data Sheets 
http://www.phac-aspc.gc.ca/msds-ftss/index.html 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp 
References 
Acha PN, Szyfres B (Pan American Health Organization 
[PAHO]). Zoonoses and Communicable Diseases Common to 
Man and Animals. Volume 3. Chlamydioses, rickettsioses, and 
viroses. 3rd ed. Washington DC: PAHO; 2003. Scientific and 
Technical Publication No. 580. Lymphocytic 
choriomeningitis; p.193-200. 
Amman BR, Pavlin BI, Albariño CG, Comer JA, Erickson BR, 
Oliver JB, Sealy TK, Vincent MJ, Nichol ST, Paddock CD, 
Tumpey AJ, Wagoner KD, Glauer RD, Smith KA, Winpisinger 
KA, Parsely MS, Wyrick P, Hannafin CH, Bandy U, Zaki S, 
Rollin PE, Ksiazek TG. Pet rodents and fatal lymphocytic 
choriomeningitis in transplant patients. Emerg Infect Dis. 
2007;13(5):719-25. 
Asper M, Hofmann P, Osmann C, Funk J, Metzger C, Bruns M, 
Kaup FJ, Schmitz H, Gunther S. First outbreak of callitrichid 
hepatitis in Germany: genetic characterization of the causative 
lymphocytic choriomeningitis virus strains. Virology. 
2001;284(2):203-13. 
Baker DG. Natural pathogens of laboratory mice, rats, and rabbits 
and their effects on research. Clin Microbiol Rev. 1998; 11(2): 
231–266. 
Barton LL, Mets MB. Congenital lymphocytic choriomeningitis 
virus infection: decade of rediscovery. Clin Infect Dis. 
2001;33(3):370-4.  
Beers MH, Berkow R, editors. The Merck manual [monograph 
online]. 17th edition. Whitehouse Station, NJ: Merck and 
Co.;1999. Lymphocytic choriomeningitis. Available at: 
http://www.merck.com/mrkshared/mmanual/section13/chapter
162/162e.jsp.* Accessed 12 March 2006. 
Bonthius DJ. Lymphocytic choriomeningitis virus: a prenatal and 
postnatal threat. Adv Pediatr. 2009;56(1):75-86. 
Bonthius DJ, Mahoney J, Buchmeier MJ, Karacay B, Taggard D. 
Critical role for glial cells in the propagation and spread of 
lymphocytic choriomeningitis virus in the developing rat 
brain. J Virol. 2002;76(13):6618-35. 
Bonthius DJ, Nichols B, Harb H, Mahoney J, Karacay B. 
Lymphocytic choriomeningitis virus infection of the 
developing brain: critical role of host age. Ann Neurol. 
2007;62(4):356-74. 
Bonthius DJ, Wright R, Tseng B, Barton L, Marco E, Karacay B, 
Larsen PD. Congenital lymphocytic choriomeningitis virus 
infection: spectrum of disease.Ann Neurol. 2007;62(4):347-
55. 
Brezin AP, Thulliez P, Cisneros B, Mets MB, Saron MF. 
Lymphocytic choriomeningitis virus chorioretinitis mimicking 
ocular toxoplasmosis in two otherwise normal children. Am J 
Ophthalmol. 2000;130(2):245-7. 
Ceianu C, Tatulescu D, Muntean M, Molnar GB, Emmerich P, 
Günther S, Schmidt-Chanasit J. Lymphocytic 
choriomeningitis in a pet store worker in Romania. Clin 
Vaccine Immunol. 2008;15(11):1749. 
Lymphocytic Choriomeningitis 
Last Updated: March 2010 © 2010 page 7 of 8 
Centers for Disease Control and Prevention. Brief report: 
Lymphocytic choriomeningitis virus transmitted through solid 
organ transplantation--Massachusetts, 2008. MMWR Morb 
Mortal Wkly Rep. 2008;57(29):799-801. 
Centers for Disease Control and Prevention. Interim guidance for 
minimizing risk for human lymphocytic choriomeningitis 
virus infection associated with rodents. Morb Mortal Wkly 
Rep. 2005;54(30):747-9. 
Centers for Disease Control and Prevention [CDC]. Lymphocytic 
choriomeningitis [online]. 2007 Oct. Available at: 
http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lcmv/
qa.htm. Accessed 9 Feb 2010. 
Centers for Disease Control and Prevention. Lymphocytic 
choriomeningitis virus infection in organ transplant recipients-
-Massachusetts, Rhode Island, 2005. Morb Mortal Wkly Rep. 
2005;54(21):537-9. 
Centers for Disease Control and Prevention [CDC]. Lymphocytic 
choriomeningitis virus (LCMV) and pregnancy facts and 
prevention [online]. 2005 Oct. Available at: 
http://www.cdc.gov/ncbddd/bd/lcmv.htm.* Accessed 9 March 
2006. 
Centers for Disease Control and Prevention [CDC]. Lymphocytic 
choriomeningitis virus from pet rodents [online]. 2007 June. 
Available at: http://www.cdc.gov/ 
healthypets/lcmv_rodents.htm. Accessed 9 Feb 2010. 
Centers for Disease Control and Prevention [CDC]. Update: 
interim guidance for minimizing risk for human lymphocytic 
choriomeningitis virus infection associated with pet rodents. 
Morb Mortal Wkly Rep. 2005;54(32):799-801. 
Charrel RN, de Lamballerie X. Arenaviruses other than Lassa 
virus. Antiviral Res. 2003;57(1-2):89-100. 
Charrel RN, de Lamballerie X. Zoonotic aspects of arenavirus 
infections. Vet Microbiol. 2009 Aug 28. [Epub ahead of print] 
Charrel RN, de Lamballerie X, Emonet S. Phylogeny of the genus 
Arenavirus. Curr Opin Microbiol. 2008;11(4):362-8. 
Drosten C, Kümmerer BM, Schmitz H, Günther S. Molecular 
diagnostics of viral hemorrhagic fevers. Antiviral Res. 
2003;57(1-2):61-87. 
Emonet SF, de la Torre JC, Domingo E, Sevilla N. Arenavirus 
genetic diversity and its biological implications. Infect Genet 
Evol. 2009;9(4):417-29. 
Emonet S, Lemasson JJ, Gonzalez JP, de Lamballerie X, Charrel 
RN. Phylogeny and evolution of old world arenaviruses. 
Virology. 2006;350(2):251-7. 
Gilden DH. Arenaviruses: a neurological problem at any age. Ann 
Neurol. 2007;62(4):309-11. 
Harkness JE, Wagner JE. The biology and medicine of rabbits and 
rodents. 2nd ed. Philadelphia: Lea and Febiger; 1983. Lymphocytic 
choriomeningitis; p. 127-129. 
Hoey J. Lymphocytic choriomeningitis virus. CMAJ. 
2005;173(9):1033. 
Institute for Laboratory Animal Research (ILAR), National 
Research Council. Infectious diseases of mice and rats. 
Washington DC: National Academy Press; 1991. Lymphocytic 
choriomeningitis virus; p.199-205. 
Institute for Laboratory Animal Research (ILAR), National 
Research Council. Occupational health and safety in the care 
and use of nonhuman primates. Washington DC: National 
Academy Press; 2003. Lymphocytic choriomeningitis virus; p. 
36-37. 
Jamieson DJ, Kourtis AP, Bell M, Rasmussen SA. Lymphocytic 
choriomeningitis virus: an emerging obstetric pathogen? Am J 
Obstet Gynecol. 2006;194(6):1532-6. 
Jay MT, Glaser C, Fulhorst CF. The arenaviruses. J Am Vet Med 
Assoc. 2005;227(6):904-915 
Kahn CM, Line S, editors. Lymphocytic choriomeningitis virus 
infection (LCMV, Arenavirus). In: The Merck veterinary 
manual [online]. Whitehouse Station, NJ: Merck and Co; 
2006. Available at: 
http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/b
c/171547.htm. Accessed 8 Feb 2010. 
Lecompte E, ter Meulen J, Emonet S, Daffis S, Charrel RN. 
Genetic identification of Kodoko virus, a novel arenavirus of 
the African pigmy mouse (Mus Nannomys minutoides) in 
West Africa. Virology. 2007;364(1):178-83.  
Ledesma J, Fedele CG, Carro F, Lledó L, Sánchez-Seco MP, 
Tenorio A, Soriguer RC, Saz JV, Domínguez G, Rosas MF, 
Barandika JF, Gegúndez MI. Independent lineage of 
lymphocytic choriomeningitis virus in wood mice (Apodemus 
sylvaticus), Spain. Emerg Infect Dis. 2009;15(10):1677-80. 
Lukashevich IS, Djavani M, Rodas JD, Zapata JC, Usborne A, 
Emerson C, Mitchen J, Jahrling PB, Salvato MS. Hemorrhagic 
fever occurs after intravenous, but not after intragastric, 
inoculation of rhesus macaques with lymphocytic 
choriomeningitis virus. J Med Virol. 2002;67(2):171-86. 
Lukashevich IS, Tikhonov I, Rodas JD, Zapata JC, Yang Y, 
Djavani M, Salvato MS. Arenavirus-mediated liver pathology: 
acute lymphocytic choriomeningitis virus infection of rhesus 
macaques is characterized by high-level interleukin-6 
expression and hepatocyte proliferation. J Virol. 
2003;77(3):1727-37. 
Lutwick LI,. Arenaviruses [online]. eMedicine; 2009 May. 
Available at: http://emedicine.medscape.com/article/212356-
overview. Accessed 13 Feb 2010.  
Montali RJ, Scanga CA, Pernikoff D, Wessner DR, Ward R, 
Holmes KV. A common-source outbreak of callitrichid 
hepatitis in captive tamarins and marmosets. J Infect Dis. 
1993;167(4):946-50. 
Montali RJ, Connolly BM, Armstrong DL, Scanga CA, Holmes 
KV. Pathology and immunohistochemistry of callitrichid 
hepatitis, an emerging disease of captive New World primates 
caused by lymphocytic choriomeningitis virus. Am J Pathol. 
1995;147(5):1441-9. 
Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, Conlan S, 
Quan PL, Hui J, Marshall J, Simons JF, Egholm M, Paddock 
CD, Shieh WJ, Goldsmith CS, Zaki SR, Catton M, Lipkin WI. 
A new arenavirus in a cluster of fatal transplant-associated 
diseases. N Engl J Med. 2008;358(10):991-8.  
Peters CJ. Lymphocytic choriomeningitis virus--an old enemy up 
to new tricks. N Engl J Med. 2006;354(21):2208-11. 
Pfau CJ. Arenaviruses [monograph online]. In: Baron S, ed. 
Medical Microbiology. 4th ed. New York: Churchill 
Livingstone; 1996. Available at: 
http://gsbs.utmb.edu/microbook/ch057.htm.* Accessed 7 
March 2006. 
Lymphocytic Choriomeningitis 
Last Updated: March 2010 © 2010 page 8 of 8 
Public Health Agency of Canada, Office of Laboratory Security. 
Material Safety Data Sheet: Lymphocytic choriomeningitis virus 
[online]. Office of Laboratory Security; 2001 March. Available at: 
http://www.phac-aspc.gc.ca/msds-ftss/msds97e.html. Accessed 26 
Feb 2006. 
Sosa LE, Gupta S, Juthani-Mehta M, Hadler JL. Meningitis in a 
college student in Connecticut, 2007. J Am Coll Health. 
2009;58(1):12-4. 
Stephensen CB, Jacob JR, Montali RJ, Holmes KV, Muchmore E, 
Compans RW, Arms ED, Buchmeier MJ, Lanford RE. Isolation 
of an arenavirus from a marmoset with callitrichid hepatitis and 
its serologic association with disease. J Virol. 1991;65(8):3995-
4000. 
Wright R, Johnson D, Neumann M, Ksiazek TG, Rollin P, Keech 
RV, Bonthius DJ, Hitchon P, Grose CF, Bell WE, Bale JF Jr. 
Congenital lymphocytic choriomeningitis virus syndrome: a 
disease that mimics congenital toxoplasmosis or 
cytomegalovirus infection. Pediatrics. 1997;100(1):E9. 
 
* Link defunct as of 2012 
